Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt) S.-J. KimY. Han OriginalPaper 21 June 2004 Pages: 179 - 191
Linalool suppresses voltage-gated currents in sensory neurons and cerebellar Purkinje cells K. NarusuyeF. KawaiE. Miyachi OriginalPaper 10 September 2004 Pages: 193 - 203
Localised astroglial dysfunction disrupts high-frequency EEG rhythms J. O. WilloughbyL. MackenzieM. Nilsson OriginalPaper 10 September 2004 Pages: 205 - 213
Botulinum toxin type A in experimental neuropathic pain L. Bach-RojeckyM. ReljaZ. Lacković OriginalPaper Pages: 215 - 219
An open-label evaluation of the tolerability and safety of Stalevo® (carbidopa, levodopa and entacapone) in Parkinson’s disease patients experiencing wearing-off W. KollerM. GuarnieriD. Silver OriginalPaper 22 October 2004 Pages: 221 - 230
Pergolide effect on cognitive functions in early-mild Parkinson’s disease L. BrusaP. TiraboschiP. Stanzione OriginalPaper 10 September 2004 Pages: 231 - 237
Amyloid precursor protein (APP) and its derivatives change after cellular energy depletion. An in vitro-study A. HoyerH. J. BardenheuerK. Plaschke OriginalPaper 30 June 2004 Pages: 239 - 253
Effect of memantine on the α7 neuronal nicotinic receptors, synaptophysin- and low molecular weight MAP-2 levels in the brain of transgenic mice over-expressing human acetylcholinesterase C. UngerM. M. SvedbergA. Nordberg OriginalPaper 14 September 2004 Pages: 255 - 268
Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer’s disease with the neurotrophic compound Cerebrolysin™ E. RockensteinA. AdameE. Masliah OriginalPaper 07 July 2004 Pages: 269 - 282
Event-related potential correlates selectively reflect cognitive dysfunction in schizophrenics H. M. OlbrichH. MaesB. Feige OriginalPaper 20 July 2004 Pages: 283 - 295
CSF homocysteine is not elevated in schizophrenia J. LevineG. AgamR. H. Belmaker OriginalPaper Pages: 297 - 302
Association study of the frizzled-3 (FZD3) gene with schizophrenia and mood disorders R. HashimotoT. SuzukiH. Kunugi OriginalPaper Pages: 303 - 307
Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients G. ZalsmanG. M. AndersonA. Apter OriginalPaper Pages: 309 - 315